why choose us

First received: June 02, 2023

Clinical Trial: Technical Feasibility of the cfDNA Test for Non-invasive Cytogenetic Analysis of Early Miscarriages Versus the Gold Standard Microarray

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Spontaneous Miscarriage

Study Type: OBSERVATIONAL


Official Title: Technical Feasibility of the Cell-free DNA Test for Non-invasive Cytogenetic Analysis of Early Miscarriages Versus the Gold Standard Microarray

Brief Summary: Among the 15% of couples who experience a spontaneous early miscarriage (SEM) during their pregnancy, approximately 2 to 5% will suffer from recurrent SEM.It is only after the third SM that they will be offered a workup to look for a predisposition to SEM.This workup does not currently include a search for foetal chromosomal abnormalities that could be considered causal for this event.These anomalies are responsible for approximately 50% of SEM and their detection could lead to an explanation for half of the…

Read more